Assessment of the In vivo Antitumor Effects of ENMD-2076, a Novel Multitargeted Kinase Inhibitor, against Primary and Cell Line–Derived Human Colorectal Cancer Xenograft Models

PURPOSE: This in vivo study was designed to investigate the efficacy of ENMD-2076, a small-molecule kinase inhibitor with activity against the Aurora kinases A and B, and several other tyrosine kinases linked to cancer, including vascular endothelial growth factor receptor 2, cKit, and fibroblast gr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Tentler, John J., Bradshaw-Pierce, Erica L., Serkova, Natalie J., Hasebroock, Kendra M., Pitts, Todd M., Diamond, Jennifer R., Fletcher, Graham C., Bray, Mark R., Eckhardt, S. Gail
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2010
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3928713/
https://ncbi.nlm.nih.gov/pubmed/20406842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-0325
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak